Alcohol Starch Sugar Enzymes - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The alcohol starch sugar enzymes market size is projected to grow from USD 2.04 billion in 2025 to USD 2.14 billion in 2026, and to USD 2.76 billion by 2031, registering a CAGR of 5.22% during the 2026-2031 forecast period. This report is segmented by Type (Amylase, Cellulase, and More), Form (Powder and Liquid), Source (Microbial, Plant-Derived, and More), End-Use Application (Alcohol Production, Starch Processing, and More), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Alcohol Starch Sugar Enzymes Market Trends and Insights

Expanding Bioethanol Production and Blending Mandates

The continued expansion of bioethanol production, supported by government-mandated fuel-blending programs in major markets, is increasing demand for enzymes for alcohol, starch and sugar. Amylase and glucoamylase are particularly important in ethanol manufacturing, as they facilitate starch liquefaction and saccharification, improving the conversion of feedstocks into fermentable sugars. According to the United States Department of Agriculture (USDA), India’s ethanol production reached 10.5 billion liters in calendar year 2025, representing a 46% increase over 2024 and underscoring the country’s rapidly expanding biofuel production capacity. India’s E20 blending target, Brazil’s E30 mandate, and Vietnam’s E10 rollout are also prompting ethanol producers to expand capacity and improve process efficiency. As ethanol output rises, producers require larger volumes of enzymes to support efficient starch conversion, fermentation, and overall production performance, creating a relatively stable and sustained demand base for enzyme suppliers.

Growing Demand for Enzymes in Starch and Sugar Processing

Rising global sugar production is driving demand for enzymes that support sugar and starch conversion processes. According to the Organization for Economic Co-operation and Development (OECD), global sugar production is projected to increase from 178 million tonnes during the base period to 205 million tonnes by 2034. Asia is expected to account for 63% of this growth, while Latin America is projected to contribute 24%, underscoring the importance of these regions in the expansion of global sugar production. As production volumes increase, sugar processors are likely to require higher volumes of enzymes, including amylase, glucoamylase, and glucose isomerase, to optimize starch hydrolysis, improve sugar conversion rates, and enhance overall processing efficiency. This trend is expected to create significant demand for enzyme solutions, particularly in the rapidly expanding sugar-processing industries in Asia and Latin America.

High Cost of Industrial Enzymes and Enzyme-Based Processing

The high cost of industrial enzymes and associated enzyme-based processing systems can restrain their adoption, especially among small and mid-sized alcohol, starch, and sugar processors. Enzyme procurement, storage, handling, and dosing requirements can increase overall production costs, particularly when plants operate below optimal capacity. Under these conditions, processors may view investments in premium or advanced enzyme solutions as less financially viable, despite their potential benefits in terms of improved yields, process efficiency, and product quality. This constraint is particularly pronounced in emerging markets, where processors often operate with narrower margins, limited capital availability, and greater sensitivity to input costs. To address these challenges, enzyme manufacturers are developing higher-activity formulations that require lower application doses, along with simplified dosing systems that reduce operational complexity. These innovations aim to improve the cost-effectiveness of enzyme-based processing and enhance its economic value for a broader range of end users.

Other drivers and restraints analyzed in the detailed report include:

• Rising Production of Beer, Spirits, and Other Alcoholic Beverages
• Increasing Adoption of Enzyme-Based Processing for Higher Production Efficiency
• Strict Regulatory Requirements for Enzyme Use in Food And Beverage Applications

Segment Analysis

Amylase dominated the alcohol starch sugar enzymes market by type, accounting for 47.13% of the market share in 2025. The enzyme plays a critical role in starch liquefaction and hydrolysis, making it essential for alcohol, starch, and sugar processing applications. It converts complex starch molecules into simpler sugars, which are subsequently used in fermentation and other downstream processing stages. The growing demand for higher starch-conversion efficiency, improved process yields, and reduced production time continues to drive amylase adoption across processing facilities. Its broad applicability across grain-based ethanol production, brewing, and sweetener manufacturing further strengthens its leading market position.

Cellulase is projected to be the fastest-growing enzyme type, registering a 6.07% CAGR through 2031. Increasing use of cellulose-rich feedstocks is driving demand for cellulase in biomass conversion and fermentation processes. The enzyme breaks down cellulose into fermentable sugars, enabling the efficient use of agricultural residues and other lignocellulosic materials. Its ability to improve feedstock utilization and support cost-effective downstream production is expanding its use in industrial applications. Rising investments in biofuels and the growing preference for renewable feedstocks are expected to further accelerate growth in the cellulase segment.

Liquid formulations dominated the alcohol starch sugar enzymes market by form, accounting for 62.64% of the market share in 2025. Their ease of handling, rapid dispersion, and compatibility with automated dosing systems support their extensive use in industrial operations. Manufacturers can directly add liquid enzymes to processing streams, enabling accurate dosing and reducing preparation time. These formulations also support consistent enzyme activity during alcohol production, starch conversion, and sugar processing. Their operational convenience and broad application base continue to reinforce the segment’s leading position.

Powder formulations are projected to be the fastest-growing form segment, registering a 6.54% CAGR through 2031. Their extended shelf life, improved storage stability, and ease of transportation make them suitable for manufacturers seeking flexible enzyme solutions. Powder enzymes can be stored and distributed efficiently, particularly in regions where cold-chain infrastructure is limited. They also provide formulation flexibility and can help reduce logistics and storage costs. Growing demand for cost-effective, stable, and easily manageable enzyme products is expected to drive segment growth.

Complete Report Scope:

• By Type
  • Amylase
  • Glucoamylase
  • Cellulase
  • Protease
  • Lipase
  • Others
• By Form
  • Powder
  • Liquid
• By Source
  • Microbial
  • Plant-Derived
  • Animal-Derived
• By End-Use Application
  • Alcohol Production
  • Starch Processing
  • Sugar Processing
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • Rest of Middle East and Africa

Geography Analysis

Asia-Pacific accounted for 33.86% of the alcohol starch sugar enzymes market in 2025 and is projected to register a 6.82% CAGR through 2031, making it the fastest-growing regional market. The region benefits from expanding ethanol production, increasing starch-processing capacity, and the growing adoption of enzyme-based conversion technologies. India’s expanding bioethanol industry and rising grain-based ethanol production are contributing significantly to regional demand for enzymes. Growing food, beverage, and fermentation activities across China, India, and Southeast Asia are also increasing the use of enzymes to improve production efficiency and yields.

North America and Europe remain established markets for alcohol starch sugar enzymes, supported by mature ethanol, food-processing, starch, and sugar industries. Manufacturers in these regions widely use enzymes for starch conversion, sweetener production, fermentation, and biofuel applications. Demand is further supported by the continued focus on improving process efficiency, product consistency, and resource utilization across industrial operations. Ongoing investments in sustainable processing technologies are expected to maintain demand for specialized enzyme solutions in both regions.

Latin America is gaining importance in the alcohol starch sugar enzymes market, supported by expanding ethanol production and increasing use of corn and other agricultural feedstocks. The Middle East and Africa represent comparatively smaller but emerging markets, where developing food-processing, beverage, and industrial biotechnology activities support gradual enzyme adoption. Regional growth through 2031 is expected to remain closely linked to investments in biofuels, agricultural processing, and industrial biotechnology infrastructure. While Asia-Pacific is likely to maintain its growth advantage, Latin America and the Middle East & Africa offer additional opportunities as local production and processing capacities expand.

List of Companies Covered in this Report:

• Novonesis A/S
• International Flavors & Fragrances Inc. (IFF)
• DSM-Firmenich AG
• Associated British Foods plc (AB Enzymes)
• Advanced Enzyme Technologies Limited
• Amano Enzyme Inc.
• Codexis, Inc.
• Dyadic International, Inc.
• Lesaffre
• Roquette Frères
• The Soufflet Group
• BASF SE
• Kerry Group plc
• Lallemand Inc.
• AEB Group
• Angel Yeast Co., Ltd.
• Biocatalysts Ltd.
• WeissBioTech GmbH
• Enzyme Development Corporation
• Aumgene Biosciences

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support